| 5-Fu | Fluorouracil |
| A375 | Human malignant melanoma |
| A549 | Human lung carcinoma |
| AIF | Apoptosis inducing factor |
| AKR1B10 | Aldo-keto reductase family 1 member B10 |
| AKT/PKB | Protein kinase B |
| AMPK | Adenosine monophosphate -activated protein kinase |
| ATP | Adenosine triphosphate |
| Aβ | Amyloid-β |
| Bax | Bcl-2-associated X |
| BChE | Butyrylcholinesterase |
| BGC-823 | Gastric carcinoma |
| C6 | Rat glial tumor |
| CaMKII | Ca2+/calmodulin-dependent protein kinase II |
| Cdc2 | Cyclin-dependent protein kinase 2 |
| Cdc25C | Cell division cycle 25C protein |
| CGC | Cerebellar granule cells |
| CNS | Central nervous system |
| CoA | Coenzyme A |
| CUS | Chronic unpredictable stress |
| DNA | Deoxyribonucleic acid |
| DNCB | 2,4-Dinitrochlorobenzene |
| DPP-IV | Dipeptidyl peptidase IV |
| DPT | Deoxypodophyllotoxin |
| DPT-HP-β-CD | Mixture of deoxypodophyllotoxin with hydroxypropyl-β-cyclodextrin |
| DU145 | Human prostate cancer |
| DZR | Dexrazoxane |
| EC50 | Half maximal effective concentration |
| EJ138 | Human bladder carcinoma |
| ERK | Extracellular signal-regulated kinase |
| FAD | Flavin adenine dinucleotide |
| GIP | Glucose-dependent insulinotropic polypeptide |
| GLP-1 | Glucagon-like peptide 1 |
| GSH | Glutathione |
| H9c2 | Rat cardiomyoblasts |
| HaCaT | Nontumorigenic human epidermal cells |
| HCT-8 | Human colorectal adenocarcinoma |
| HCT116 | Human colon cancer |
| HeLa | Human cervical carcinoma |
| Hep3B | Human hepatoma |
| HepG2 | Human hepatocellular carcinoma |
| HFF-1 | Human normal fibroblast |
| HL-7702 | Human liver normal |
| HO-8910 | Human ovarian carcinoma |
| HT-29 | Human colon carcinoma |
| HUVEC | Human umbilical vein endothelial cells |
| IC50 | Half maximal inhibitory concentration |
| IgE | Immunoglobulin E |
| IL-4 | Interleukin 4 |
| JeG-3 | Human choriocarcinoma |
| L-02 | Human fetal hepatocyte normal cell line |
| LTP | Long-term potentiation |
| MCF-7/A | Acquired resistant human breast cancer |
| MCF-7/S | Human breast cancer |
| MCF-7 | Human breast cancer |
| MDA-MB-231 | Human breast adenocarcinoma |
| MDCK | Madin-Darby canine kidney cells |
| MGC-803 | Human gastric cancer |
| Mia-PaCa2 | Human pancreatic carcinoma |
| MIC | Minimum inhibitory concentration |
| MMP | Mitochondrial membrane potential |
| MMP-9 | Matrix metallopeptidase 9 |
| MPP+ | 1-methyl-4-phenylpyridinium |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| mTOR | Mammalian target of rapamycin |
| N2A | Mouse neuroblastoma |
| NAD(P)+ | Nicotinamide adenine dinucleotide phosphate |
| NCI-H460 | Human lung carcinoma |
| NO | Nitric oxide |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| OVCAR-3 | Human ovarian adenocarcinoma |
| PAR | Poly (ADP-ribose) |
| PARP-1 | Poly (ADP-ribose) synthetase 1 |
| PBPK-PD | Physiologically based pharmacokinetic-pharmacodynamic |
| PC-3 | Human prostate cancer |
| PGD2 | Prostaglandin D2 |
| PKB/HO-1 | Protein kinase B/heme oxygenase-1 |
| PKC | Protein kinase C |
| PTEN | Phosphatase and tensin homolog |
| RAW 267.4 | Macrophage normal cell line |
| RNA | Ribonucleic acid |
| ROS | Reactive oxygen species |
| SF126 | Human glioblastoma |
| SGC-7901 | Gastric carcinoma |
| SHG-44 | Human malignant glioma |
| SI | Selective index |
| SK-OV-3 | Ovarian cancer |
| Skp2 | S-phase kinase protein 2 |
| SOD | Superoxide dismutase |
| STAT3 | Signal transducer and activator of transcription 3 |
| TGF | Transforming growth factor |
| TIMP-1 | TIMP metallopeptidase inhibitor 1 |
| TKT | Transketolase |
| TNF-α | Tumor necrosis factor α |
| U-87 MG | Human glioblastoma-astrocytoma |
| VGSC | Voltage-gated Na+ channels |
| WI-38 | Human lung fibroblast normal cells |